Movahedi H, Purdy R E
Department of Pharmacology, College of Medicine, University of California, Irvine, California 92697-4625, USA.
J Pharmacol Exp Ther. 1997 Nov;283(2):653-60.
Serotonin acts on 5-hydroxytryptamine (5-HT)1B-like receptors in isolated rabbit ear artery precontracted with phenylephrine (PHE). These receptors are inactive, or "silent," in untreated vessels. Ear artery rings were mounted in tissue baths for the measurement of isometric contraction to further characterize these 5-HT1B-like receptors. The 5-HT1-selective receptor agonist sumatriptan failed to contract the untreated ear artery rings but caused a powerful, concentration-dependent contraction in PHE-precontracted vessels. The 5-HT1A/rat 1B receptor antagonist propranolol (1 microM) had no effect, whereas the 5-HT1B receptor antagonists rauwolscine (0.1 microM) and GR127935 (1-100 nM) markedly inhibited the contraction to sumatriptan. In vessels precontracted with phenylephrine, nifedipine reduced and calcium-free medium abolished the contractile response to serotonin. Relaxation to the adenylate cyclase activator forskolin was studied in contracted ear artery rings. Low concentrations (0.1-0.3 microM) of forskolin rapidly and completely relaxed ear artery rings contracted with PHE. In contrast, when PHE-precontracted vessels were contracted with either serotonin or sumatriptan, forskolin caused little or no relaxation at low concentrations and only partial relaxation at 10- to 30-fold higher concentrations. The resistance of these vessels to relaxation by forskolin was markedly reduced in the presence of GR127935 or in ear artery rings from pertussis toxin-treated rabbits. However, pertussis toxin treatment had no effect on the contractile response of PHE-precontracted ear artery rings to serotonin. It is concluded that the silent 5-HT1-like receptor of rabbit ear artery closely resembles the 5-HT1B receptor subtype. This receptor is inversely coupled to adenylate cyclase through a pertussis toxin-sensitive G protein; however, this coupling is unlikely to contribute to the serotonin-induced contraction of PHE-precontracted ear artery rings. Instead, this contraction is mediated at the second-messenger level by pertussis toxin-insensitive influx of calcium.
血清素作用于预先用去氧肾上腺素(PHE)预收缩的离体兔耳动脉中的5-羟色胺(5-HT)1B样受体。这些受体在未处理的血管中是无活性的,或“沉默”的。将耳动脉环安装在组织浴中以测量等长收缩,以进一步表征这些5-HT1B样受体。5-HT1选择性受体激动剂舒马曲坦未能使未处理的耳动脉环收缩,但在PHE预收缩的血管中引起强烈的、浓度依赖性收缩。5-HT1A/大鼠1B受体拮抗剂普萘洛尔(1 microM)无作用,而5-HT1B受体拮抗剂利血平(0.1 microM)和GR127935(1-100 nM)显著抑制对舒马曲坦的收缩。在用去氧肾上腺素预收缩的血管中,硝苯地平降低了收缩反应,无钙培养基消除了对血清素的收缩反应。在收缩的耳动脉环中研究了对腺苷酸环化酶激活剂福斯高林的舒张作用。低浓度(0.1-0.3 microM)的福斯高林能迅速且完全地舒张用PHE收缩的耳动脉环。相反,当PHE预收缩的血管用血清素或舒马曲坦收缩时,福斯高林在低浓度时几乎不引起舒张或根本不引起舒张,在高10至30倍的浓度时仅引起部分舒张。在存在GR127935的情况下或在百日咳毒素处理的兔子的耳动脉环中,这些血管对福斯高林舒张的抗性明显降低。然而,百日咳毒素处理对PHE预收缩的耳动脉环对血清素的收缩反应没有影响。结论是,兔耳动脉的沉默5-HT1样受体与5-HT1B受体亚型非常相似。该受体通过百日咳毒素敏感的G蛋白与腺苷酸环化酶反向偶联;然而,这种偶联不太可能导致血清素诱导的PHE预收缩耳动脉环的收缩。相反,这种收缩是由百日咳毒素不敏感的钙内流在第二信使水平介导的。